Provided by Tiger Trade Technology Pte. Ltd.

INSILICO

57.600
-2.500-4.16%
Volume:4.12M
Turnover:232.69M
Market Cap:33.58B
PE:-12.86
High:57.700
Open:57.000
Low:55.700
Close:60.100
52wk High:80.900
52wk Low:29.980
Shares:583.00M
HK Float Shares:583.00M
Volume Ratio:0.34
T/O Rate:0.71%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-4.480
ROE:--
ROA:-1.36%
PB:7.82
PE(LYR):-12.86
PS:31.68

Loading ...

Insilico Medicine Cayman Topco - Insilico Medicine is Eligible to Receive Milestone Payments Totaling up to Approximately Rmb1.2 Bln

THOMSON REUTERS
·
Jul 13

Movement Alert|Insilico Medicine Rises 5.92% in Regular Trading, Positive Profit Warning Signals First-Half Turnaround to Profitability

Market Focus
·
Jul 10

Here's Why We're Not At All Concerned With InSilico Medicine Cayman TopCo's (HKG:3696) Cash Burn Situation

Simply Wall St.
·
Jul 10

Movement Alert|Insilico Medicine Rises 5.89% in Regular Trading, Issues Positive Profit Warning Expecting H1 Turnaround to Profitability

Market Focus
·
Jul 09

INSILICO issues positive profit warning, forecasting a swing to USD33.50–39.50 million H1 2026 profit on revenue surge to over USD100 million

Bulletin Express
·
Jul 09

Insilico Projects Significant Turnaround with Profit Forecast for First Half of 2026

Stock News
·
Jul 09

Insilico Medicine Cayman Topco - Expects H1 2026 Revenue of Usd102.5 Mln-usd106.5 Mln, up 272.7%-287.3% Y/Y

THOMSON REUTERS
·
Jul 09

Insilico Medicine Expects H1 2026 Net Profit of USD 33.5 Million-usd 39.5 Million

Reuters
·
Jul 09

Insilico Medicine Begins Phase 3 Trial of Lung Disease Drug; Shares Up 3%

MT Newswires Live
·
Jul 08

Movement Alert|Insilico Medicine Rises 5.16% in Regular Trading, First AI-Discovered Drug Rentosertib Enters Phase III Clinical Trial

Market Focus
·
Jul 08

Insilico Commences Phase 3 Trial for Rentosertib

Stock News
·
Jul 08

Insilico Medicine Initiates Phase III Trial of IPF Drug Rentosertib

Reuters
·
Jul 07

Insilico Initiates Phase Iii Clinical Trial for Rentosertib, Its Ai-empowered Tnik Inhibitor for Idiopathic Pulmonary Fibrosis

THOMSON REUTERS
·
Jul 07

Movement Alert|Insilico Medicine Falls 5.11% in Regular Trading, Takeda Deal Gains Fully Priced In Amid Continued Lock-Up Selling Pressure

Market Focus
·
Jul 07

INSILICO expands share capital by 0.53% through option exercises and award vesting

Bulletin Express
·
Jul 06

Insilico Medicine Files HKEX Next-day Disclosure Return, Share Capital Rises by 3,052,484 Shares

Reuters
·
Jul 06

Movement Alert|Insilico Medicine Falls 6.32% in Regular Trading, Post-Takeda Deal Selling Pressure Persists

Market Focus
·
Jul 03

PRESS Digest -wall Street Journal - July 2

Reuters
·
Jul 02

Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery

THOMSON REUTERS
·
Jul 02

Insilico Medicine Cayman Topco: Total Deal Value to Approximately $600 Mln

THOMSON REUTERS
·
Jul 02